LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates
Purcell, James W, Tanlimco, Sonia G, Hickson, Jonathan, Fox, Melvin, Sho, Mien, Durkin, Lisa, Uziel, Tamar, Powers, Rick, Foster, Kelly, McGonigal, Thomas, Kumar, Subashri, Samayoa, Josue, Zhang, Dong, Palma, Joann P, Mishra, Sasmita, Hollenbaugh, Diane, Gish, Kurt, Morgan-Lappe, Susan E, Hsi, Eric D, Chao, Debra T
Published in Cancer research (Chicago, Ill.) (15.07.2018)
Published in Cancer research (Chicago, Ill.) (15.07.2018)
Get full text
Journal Article
Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors
Phillips, Darren C, Buchanan, Fritz G, Cheng, Dong, Solomon, Larry R, Xiao, Yu, Xue, John, Tahir, Stephen K, Smith, Morey L, Zhang, Haichao, Widomski, Deborah, Abraham, Vivek C, Xu, Nan, Liu, Zhihong, Zhou, Li, DiGiammarino, Enrico, Lu, Xin, Rudra-Ganguly, Nandini, Trela, Bruce, Morgan-Lappe, Susan E
Published in Cancer research (Chicago, Ill.) (15.06.2021)
Published in Cancer research (Chicago, Ill.) (15.06.2021)
Get full text
Journal Article
Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors
Gordon, Michael S, Nemunaitis, John, Barve, Minal, Wainberg, Zev A, Hamilton, Erika P, Ramanathan, Ramesh K, Sledge, Jr, George W, Yue, Huibin, Morgan-Lappe, Susan E, Blaney, Martha, Kasichayanula, Sreeneeranj, Motwani, Monica, Wang, Lan, Naumovski, Louie, Strickler, John H
Published in Molecular cancer therapeutics (01.10.2021)
Published in Molecular cancer therapeutics (01.10.2021)
Get full text
Journal Article
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737
TAHIR, Stephen K, XIUFEN YANG, ROSENBERG, Saul H, TSE, Christin, ANDERSON, Mark G, MORGAN-LAPPE, Susan E, SARTHY, Aparna V, JUN CHEN, WARNER, Robert B, NG, Shi-Chung, FESIK, Stephen W, ELMORE, Steve W
Published in Cancer research (Chicago, Ill.) (01.02.2007)
Published in Cancer research (Chicago, Ill.) (01.02.2007)
Get full text
Journal Article
ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models
Li, Yingchun, Hickson, Jonathan A, Ambrosi, Dominic J, Haasch, Deanna L, Foster-Duke, Kelly D, Eaton, Lucia J, DiGiammarino, Enrico L, Panchal, Sanjay C, Jiang, Fang, Mudd, Sarah R, Zhang, Catherine, Akella, Surekha S, Gao, Wenqing, Ralston, Sherry L, Naumovski, Louie, Gu, Jijie, Morgan-Lappe, Susan E
Published in Molecular cancer therapeutics (01.05.2018)
Published in Molecular cancer therapeutics (01.05.2018)
Get full text
Journal Article
Identification of ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-coa desaturase 1 as promising cancer targets from an RNAi-based screen
MORGAN-LAPPE, Susan E, TUCKER, Lora A, XIAOLI HUANG, QIAN ZHANG, SARTHY, Aparna V, ZAKULA, Dorothy, VERNETTI, Lawrence, SCHURDAK, Mark, JIEYI WANG, FESIK, Stephen W
Published in Cancer research (Chicago, Ill.) (01.05.2007)
Published in Cancer research (Chicago, Ill.) (01.05.2007)
Get full text
Journal Article
Growth Inhibition and Radiosensitization of Glioblastoma and Lung Cancer Cells by Small Interfering RNA Silencing of Tumor Necrosis Factor Receptor-Associated Factor 2
MIN ZHENG, MORGAN-LAPPE, Susan E, JIE YANG, BOCKBRADER, Katrina M, PAMARTHY, Deepika, THOMAS, Dafydd, FESIK, Stephen W, YI SUN
Published in Cancer research (Chicago, Ill.) (15.09.2008)
Published in Cancer research (Chicago, Ill.) (15.09.2008)
Get full text
Journal Article
Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells
Sarthy, Aparna V, Morgan-Lappe, Susan E, Zakula, Dorothy, Vernetti, Lawrence, Schurdak, Mark, Packer, Jeremy C L, Anderson, Mark G, Shirasawa, Senji, Sasazuki, Takehiko, Fesik, Stephen W
Published in Molecular cancer therapeutics (01.01.2007)
Published in Molecular cancer therapeutics (01.01.2007)
Get full text
Journal Article
Abstract 940: The combinatorial activity of Eftozanermin ABBV621, a novel and potent TRAIL receptor agonist fusion protein, in pre-clinical models of hematologic malignancies
Smith, Morey, Jin, Sha, Cheng, Dong, Zhang, Haichao, Huska, Jason, Widomski, Deborah, Bontcheva, Vicky, Buchanan, Greg, Morgan-Lappe, Susan, Phillips, Darren, Tahir, Stephen
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia
Tahir, Stephen K., Calvo, Emiliano, Carneiro, Benedito A., Yuda, Junichiro, Shreenivas, Aditya, Jongen-Lavrencic, Mojca, Gort, Eelke, Ishizawa, Kenichi, Morillo, Daniel, Biesdorf, Carla, Smith, Morey, Cheng, Dong, Motwani, Monica, Sharon, David, Uziel, Tamar, Modi, Dimple A., Buchanan, Fritz G., Morgan-Lappe, Susan, Medeiros, Bruno C., Phillips, Darren C.
Published in Blood (27.04.2023)
Published in Blood (27.04.2023)
Get full text
Journal Article
The Combinatorial Activity of Eftozanermin (ABBV-621), a Novel and Potent TRAIL Receptor Agonist Fusion Protein, in Pre-Clinical Models of Hematologic Malignancies
Smith, Morey L, Jin, Sha, Chen, Dong, Zhang, Haichao, Huska, Jason, Widomski, Deborah, Bontcheva, Vicky, Buchanan, Greg, Morgan-Lappe, Susan, Phillips, Darren C., Tahir, Stephen K
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate
Singh, Shweta, Serwer, Laura, DuPage, Amy, Elkins, Kristi, Chauhan, Niharika, Ravn, Matthew, Buchanan, Fritz, Wang, Leyu, Krimm, Michael, Wong, Ken, Sagert, Jason, Tipton, Kimberly, Moore, Stephen J, Huang, Yuanhui, Jang, Andrew, Ureno, Eric, Miller, Adam, Patrick, Sarah, Duvur, Shanti, Liu, Shouchun, Vasiljeva, Olga, Li, Yingchun, Henriques, Tracy, Badagnani, Ilaria, Jeffries, Shawn, Schleyer, Siew, Leanna, Rob, Krebber, Claus, Viswanathan, Sridhar, Desnoyers, Luc, Terrett, Jonathan, Belvin, Marcia, Morgan-Lappe, Susan, Kavanaugh, W Michael, Richardson, Jennifer
Published in Molecular cancer therapeutics (02.08.2022)
Published in Molecular cancer therapeutics (02.08.2022)
Get full text
Journal Article
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies
Chang, Chewei Anderson, Emberley, Ethan, D'Souza, Aloma L., Zhao, Weilong, Cosgrove, Cormac, Parrish, Karen, Mitra, Diya, Payson, Elmer, Oleksijew, Anatol, Ellis, Paul, Rodriguez, Luis, Duggan, Ryan, Hrusch, Cara, Lasko, Loren, Assaily, Wissam, Zheng, Pingping, Liu, Wei, Hernandez, Axel, McCarthy, Kimberley, Zhang, Zhaomei, Rha, Geunbae, Cao, Zhensheng, Li, Yingchun, Perng, Olivia, Campbell, Jos, Zhang, Gloria, Curran, Tyler, Bruncko, Milan, Marvin, Christopher C., Hobson, Adrian, McPherson, Michael, Uziel, Tamar, Pysz, Marybeth A., Zhao, Xi, Bankovich, Alex, Hayflick, Joel, McDevitt, Michael, Freise, Kevin J., Morgan-Lappe, Susan, Purcell, James W.
Published in Blood (15.08.2024)
Published in Blood (15.08.2024)
Get full text
Journal Article
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
LoRusso, Patricia, Ratain, Mark J., Doi, Toshihiko, Rasco, Drew W., de Jonge, Maja J. A., Moreno, Victor, Carneiro, Benedito A., Devriese, Lot A., Petrich, Adam, Modi, Dimple, Morgan-Lappe, Susan, Nuthalapati, Silpa, Motwani, Monica, Dunbar, Martin, Glasgow, Jaimee, Medeiros, Bruno C., Calvo, Emiliano
Published in Investigational new drugs (01.08.2022)
Published in Investigational new drugs (01.08.2022)
Get full text
Journal Article
Abbv-621 Is a Novel and Potent TRAIL Receptor Agonist Fusion Protein That Induces Apoptosis Alone and in Combination with Navitoclax and Venetoclax in Hematological Tumors
Tahir, Stephen Kenneth, Smith, Morey L, Solomon, Larry R, Zhang, Haichao, Xue, John C, Xiao, Yu, Cheng, Dong, Buchanan, Greg, Morgan-Lappe, Susan, Phillips, Darren C.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Abstract 953: LRRC15 is a novel antigen in sarcoma and the therapeutic target of the antibody-drug conjugate (ADC) ABBV-085
Ben-Ami, Eytan, Huang, Ying, Gokhale, Prafulla C., Eschle, Benjamin, Durkin, Lisa, Hickson, Jonathan, Sho, Mien, Morgan-Lappe, Susan, Gish, Kurt, Lai, Dominic W., Robinson, Randy R., Hollenbaugh, Diane, Hsi, Eric D., Chao, Debra T., Demetri, George D., Purcell, James W.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 867: ABT-165 is a first-in-class therapeutic Dual Variable Domain Immunoglobulin (DVD-IgTM) that targets DLL4 and VEGF for the treatment of cancer
Li, Yingchun, Hickson, Jonathan, Ambrosi, Dominic, Haasch, Deanna, Foster-Duke, Kelly, Eaton, Lucia, Jiang, Fang, Akella, Surekha, Gao, Wenqing, Ralston, Sherry, Gu, Jijie, Morgan-Lappe, Susan
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Abstract B103: A multi-analyte HPLC-MS/MS approach to assessing exposure of a Probody drug conjugate in preclinical studies
Serwer, Laura, Singh, Shweta, Krebber, Claus, Liu, Shouchun, Chauhan, Niharika, Leanna, Robert, Lu, Hong, Badagnani, Ilaria, Henriques, Tracy, Morgan-Lappe, Susan, Mylott, William, Viswanathan, Sridhar, Richardson, Jennifer, Kavanaugh, Michael
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article
CD71 ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF
SINGH SHWETA, TERRETT JONATHAN ALEXANDER, BOSE SAHANA, RICHARDSON JENNIFER HOPE, HENRIQUES TRACY, SERWER LAURA PATTERSON, LEANNA MARVIN ROBERT, BADAGNANI ILARIA, MORGAN LAPPE SUSAN E, RALSTON SHERRY L
Year of Publication 19.05.2023
Get full text
Year of Publication 19.05.2023
Patent